View in EDS HTML Full Text PDF Full Text

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.

Saved in:
Bibliographic Details
Title: A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.
Authors: DePalo DK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Dugan MM; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Naqvi SMH; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Ollila DW; University of North Carolina, Chapel Hill, North Carolina, USA., Hieken TJ; Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA., Block MS; Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA., van Houdt WJ; Netherlands Cancer Institute, Amsterdam, Netherlands., Wouters MWJM; Netherlands Cancer Institute, Amsterdam, Netherlands., Reijers SJM; Netherlands Cancer Institute, Amsterdam, Netherlands., Asher N; Skin Cancer and Melanoma Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel., Broman KK; University of Alabama at Birmingham, Birmingham, Alabama, USA.; United States Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, Alabama, USA., Duncan Z; University of Alabama at Birmingham, Birmingham, Alabama, USA., Anderson M; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Snow H; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Held J; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Farma JM; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Vetto JT; Oregon Health and Science University, Portland, Oregon, USA., Hui JYC; University of Minnesota, Minneapolis, Minnesota, USA., Kolbow M; University of Minnesota, Minneapolis, Minnesota, USA., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Kim Y; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Karapetyan L; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Ny L; Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., van Akkooi ACJ; Netherlands Cancer Institute, Amsterdam, Netherlands.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Olofsson Bagge R; Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
Source: Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35636. Date of Electronic Publication: 2024 Nov 10.
Publication Type: Journal Article; Comparative Study; Multicenter Study
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39522025
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22DePalo+DK%22">DePalo DK</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Dugan+MM%22">Dugan MM</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Naqvi+SMH%22">Naqvi SMH</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Ollila+DW%22">Ollila DW</searchLink>; University of North Carolina, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Hieken+TJ%22">Hieken TJ</searchLink>; Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Block+MS%22">Block MS</searchLink>; Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22van+Houdt+WJ%22">van Houdt WJ</searchLink>; Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wouters+MWJM%22">Wouters MWJM</searchLink>; Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Reijers+SJM%22">Reijers SJM</searchLink>; Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Asher+N%22">Asher N</searchLink>; Skin Cancer and Melanoma Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Broman+KK%22">Broman KK</searchLink>; University of Alabama at Birmingham, Birmingham, Alabama, USA.; United States Department of Veterans Affairs, Birmingham VA Medical Center, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Duncan+Z%22">Duncan Z</searchLink>; University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+M%22">Anderson M</searchLink>; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Gyorki+DE%22">Gyorki DE</searchLink>; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Snow+H%22">Snow H</searchLink>; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Held+J%22">Held J</searchLink>; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Farma+JM%22">Farma JM</searchLink>; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Vetto+JT%22">Vetto JT</searchLink>; Oregon Health and Science University, Portland, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Hui+JYC%22">Hui JYC</searchLink>; University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Kolbow+M%22">Kolbow M</searchLink>; University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Saw+RPM%22">Saw RPM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Lo+SN%22">Lo SN</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Thompson+JF%22">Thompson JF</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Karapetyan+L%22">Karapetyan L</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Ny+L%22">Ny L</searchLink>; Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22van+Akkooi+ACJ%22">van Akkooi ACJ</searchLink>; Netherlands Cancer Institute, Amsterdam, Netherlands.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Olofsson+Bagge+R%22">Olofsson Bagge R</searchLink>; Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Zager+JS%22">Zager JS</searchLink>; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35636. <i>Date of Electronic Publication: </i>2024 Nov 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39522025
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.35636
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e35636
    Titles:
      – TitleFull: A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: DePalo DK
      – PersonEntity:
          Name:
            NameFull: Dugan MM
      – PersonEntity:
          Name:
            NameFull: Naqvi SMH
      – PersonEntity:
          Name:
            NameFull: Ollila DW
      – PersonEntity:
          Name:
            NameFull: Hieken TJ
      – PersonEntity:
          Name:
            NameFull: Block MS
      – PersonEntity:
          Name:
            NameFull: van Houdt WJ
      – PersonEntity:
          Name:
            NameFull: Wouters MWJM
      – PersonEntity:
          Name:
            NameFull: Reijers SJM
      – PersonEntity:
          Name:
            NameFull: Asher N
      – PersonEntity:
          Name:
            NameFull: Broman KK
      – PersonEntity:
          Name:
            NameFull: Duncan Z
      – PersonEntity:
          Name:
            NameFull: Anderson M
      – PersonEntity:
          Name:
            NameFull: Gyorki DE
      – PersonEntity:
          Name:
            NameFull: Snow H
      – PersonEntity:
          Name:
            NameFull: Held J
      – PersonEntity:
          Name:
            NameFull: Farma JM
      – PersonEntity:
          Name:
            NameFull: Vetto JT
      – PersonEntity:
          Name:
            NameFull: Hui JYC
      – PersonEntity:
          Name:
            NameFull: Kolbow M
      – PersonEntity:
          Name:
            NameFull: Saw RPM
      – PersonEntity:
          Name:
            NameFull: Lo SN
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Thompson JF
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Karapetyan L
      – PersonEntity:
          Name:
            NameFull: Ny L
      – PersonEntity:
          Name:
            NameFull: van Akkooi ACJ
      – PersonEntity:
          Name:
            NameFull: Olofsson Bagge R
      – PersonEntity:
          Name:
            NameFull: Zager JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 131
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1